Murine and chicken chondrocytes regulate osteoclastogenesis by producing RANKL in response to BMP2

Journal of Bone and Mineral Research

Volumn 23, Issue 3, 2008, Pages 314-325

  Usui, Michihiko ^a   Xing, Lianping ^a   Drissi, Hicham ^a   Zuscik, Michael ^a   O'Keefe, Regis ^a   Chen, Di ^a   Boyce, Brendan F ^a,b  

^a UNIVERSITY OF ROCHESTER MEDICAL CENTER   (United States)

^b Box 626 ^*  (United States)

Author keywords

Bone morphogenetic protein 2; Chondrocytes; Osteoclasts; Runx2

Indexed keywords

BONE MORPHOGENETIC PROTEIN 2; LUCIFERASE; MESSENGER RNA; OSTEOCLAST DIFFERENTIATION FACTOR; SMAD1 PROTEIN; TRANSCRIPTION FACTOR RUNX2;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BINDING SITE; BONE DEVELOPMENT; CARTILAGE CELL; CELL LINE; CELL TYPE; CHICKEN; COCULTURE; CONTROLLED STUDY; EMBRYO; ENZYME ACTIVATION; ENZYME ACTIVITY; GENE DELETION; GENE MUTATION; GENE OVEREXPRESSION; MARKER GENE; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; OSTEOCLAST; PROMOTER REGION; PROTEIN BINDING; PROTEIN EXPRESSION; PROTEIN SYNTHESIS; REAL TIME POLYMERASE CHAIN REACTION; SPLEEN CELL; STEM CELL; STERNUM; TRANSCRIPTION REGULATION; WESTERN BLOTTING;

ANIMALS; BONE DEVELOPMENT; BONE MORPHOGENETIC PROTEINS; CELL DIFFERENTIATION; CELL LINE, TUMOR; CHICKENS; CHOLECALCIFEROL; CHONDROCYTES; COLLAGEN TYPE IX; CORE BINDING FACTOR ALPHA 1 SUBUNIT; EXTRACELLULAR MATRIX; FRACTURES, BONE; GENE EXPRESSION REGULATION; GROWTH PLATE; HUMANS; MICE; OSTEOCLASTS; RANK LIGAND; RESPONSE ELEMENTS; RNA, MESSENGER; SMAD1 PROTEIN; SPLEEN; STEM CELLS; TRANSFORMING GROWTH FACTOR BETA; VITAMINS;

EID: 39749130982     PISSN: 08840431     EISSN: None     Source Type: Journal    
DOI: 10.1359/jbmr.071025     Document Type: Article

References (45)

1. van der Eerden BC, Karperien M, Wit JM 2003 Systemic and local regulation of the growth plate. Endocr Rev 24:782-801.
2. Boyle WJ, Simonet WS, Lacey DL 2003 Osteoclast differentiation and activation. Nature 423:337-342.
3. Yasuda H, Shima N, Nakagawa N, Yamaguchi K, Kinosaki M, Mochizuki S, Tomoyasu A, Yano K, Goto M, Murakami A, Tsuda E, Morinaga T, Higashio K, Udagawa N, Takahashi N, Suda T 1998 Osteoclast differentiation factor is a ligand for osteoprotegerin/osteoclastogenesis-inhibitory factor and is identical to TRANCE/RANKL. Proc Natl Acad Sci USA 95:3597-3602.
4. Simonet WS, Lacey DL, Dunstan CR, Kelley M, Chang MS, Lüthy R, Nguyen HQ, Wooden S, Bennett L, Boone T, Shimamoto G, DeRose M, Elliott R, Colombero A, Tan HL, Trail G, Sullivan J, Davy E, Bucay N, Renshaw-Gegg L, Hughes TM, Hill D, Pattison W, Campbell P, Sander S, Van G, Tarpley J, Derby P, Lee P, Boyle WJ 1997 Osteoprotegerin: A novel secreted protein involved in the regulation of bone density. Cell 89:309-319.
5. Kishimoto K, Kitazawa R, Kurosaka M, Maeda S, Kitazawa S 2006 Expression profile of genes related to osteoclastogenesis in mouse growth plate and articular cartilage. Histochem Cell Biol 125:593-602.
6. Masuyama R, Stockmans I, Torrekens S, Van Looveren R, Maes C, Carmeliet P, Bouillon R, Carmeliet G 2006 Vitamin D receptor in chondrocytes promotes osteoclastogenesis and regulates FGF23 production in osteoblasts. J Clin Invest 116:3150-3159.
7. Kong YY, Yoshida H, Sarosi I, Tan HL, Timms E, Capparelli C, Morony S, Oliveira-dos-Santos AJ, Van G, Itie A, Khoo W, Wakeham A, Dunstan CR, Lacey DL, Mak TW, Boyle WJ, Penninger JM 1999 OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis. Nature 397:315-323.
8. Franzoso G, Carlson L, Xing L, Poljak L, Shores EW, Brown KD, Leonardi A, Tran T, Boyce BF, Siebenlist U 1997 Requirement for NF-kappaB in osteoclast and B-cell development. Genes Dev 11:3482-3496.
9. Roodman GD, Windle JJ 2005 Paget disease of bone. J Clin Invest 115:200-208.
10. Takuma S 1962 Electron microscopy of cartilage resorption by chondroclasts. J Dent Res 41:883-889.
11. Bettex-Galland M, Boillat C, Bettex M 1990 Chondroclasts in osteoneogenesis. Tissue Cell 22:93-100.
12. Tsumaki N, Yoshikawa H 2005 The role of bone morphogenetic proteins in endochondral bone formation. Cytokine Growth Factor Rev 16:279-285.
13. Chen D, Zhao M, Mundy GR 2004 Bone morphogenetic proteins. Growth Factors 22:233-241.
14. Kaneko H, Arakawa T, Mano H, Kaneda T, Ogasawara A, Nakagawa M, Toyama Y, Yabe Y, Kumegawa M, Hakeda Y 2000 Direct stimulation of osteoclastic bone resorption by bone morphogenetic protein (BMP)-2 and expression of BMP receptors in mature osteoclasts. Bone 27:479-486.
15. Itoh K, Udagawa N, Katagiri T, Iemura S, Ueno N, Yasuda H, Higashio K, Quinn JMW, Gillespie MT, Martin TJ, Suda T, Takahashi N 2001 Bone morphogenetic protein 2 stimulates osteoclast differentiation and survival supported by receptor activator of nuclear factor-kappaB ligand. Endocrinology 142:3656-3662.
16. Shukunami C, Shigeno C, Atsumi T, Ishizeki K, Suzuki F, Hiraki Y 1996 Chondrogenic differentiation of clonal mouse embryonic cell line ATDC5 in vitro: Differentiation-dependent gene expression of parathyroid hormone (PTH)/PTH-related peptide receptor. J Cell Biol 133:457-468.
17. Grimsrud CD, Romano PR, D'Souza M, Puzas JE, Reynolds PR, Rosier RN, O'Keefe RJ 1999 BMP-6 is an autocrine stimulator of chondrocyte differentiation. J Bone Miner Res 14:475-482.
18. Kaneki H, Guo R, Di Chen D, Yao Z. Schwarz EM, Zhang YE, Boyce BF, Xing L 2006 Tumor necrosis factor promotes Runx2 degradation through up-regulation of Smurf1 and Smurf2 in osteoblasts. J Biol Chem 281:4326-4333.
19. Xing L, Bushnell TP, Carlson L, Tai Z, Tondravi M, Siebenlist U, Young F, Boyce BF 2002 NF-kappaB p50 and p52 expression is not required for RANK-expressing osteoclast progenitor formation but is essential for RANK- and cytokine-mediated osteoclastogenesis. J Bone Miner Res 17:1200-1210.
20. Shen R, Chen M, Wang YJ, Kaneki H, Xing L, O'Keefe RJ, Chen D 2006 Smad6 interacts with Runx2 and mediates Smad ubiquitin regulatory factor 1-induced Runx2 degradation. J Biol Chem 281:3569-3576.
21. O'Brien CA, Kern B, Gubrij I, Karsenty G, Manolagas SC 2002 Cbfa1 does not regulate RANKL gene activity in stromal/osteoblastic cells. Bone 30:453-462.
22. Horwood NJ, Elliott J, Martin TJ, Gillespie MT 1998 Osteotropic agents regulate the expression of osteoclast differentiation factor and osteoprotegerin in osteoblastic stromal cells. Endocrinology 139:4743-4746.
23. Otsuka E, Notoya M, Hagiwara H 2003 Treatment of myoblastic C2C12 cells with BMP-2 stimulates vitamin D-induced formation of osteoclasts. Calcif Tissue Int 73:72-77.
24. Barnes GL, Della Torre T, Sommer B, Young MF, Gerstenfeld LC 2002 Transcriptional regulation restricting bone sialoprotein gene expression to both hypertrophic chondrocytes and osteoblasts. J Cell Biochem 87:458-469.
25. Stanton L-A, Sabari S, Sampaio AV, Underhill TM, Beier F 2004 p38 MAP kinase signalling is required for hypertrophic chondrocyte differentiation. Biochem J 378:53-62.
26. Kawabata M, Imamura T, Miyazono K 1998 Signal transduction by bone morphogenetic proteins. Cytokine Growth Factor Rev 9:49-61.
27. Lee KS, Kim HJ, Li QL, Chi XZ, Ueta C, Komori T, Wozney JM, Kim EG, Choi JY, Ryoo HM, Bae SC 2000 Runx2 is a common target of transforming growth factor beta1 and bone morphogenetic protein 2, and cooperation between Runx2 and Smad5 induces osteoblast-specific gene expression in the pluripotent mesenchymal precursor cell line C2C12. Mol Cell Biol 20:8783-8792.
28. Pacifici M, Golden EB, Oshima O, Shapiro IM, Leboy PS, Adams SL 1990 Hypertrophic chondrocytes. The terminal stage of differentiation in the chondrogenic cell lineage? Ann NY Acad Sci 599:45-57.
29. Kartsogiannis V, Zhou H, Horwood NJ, Thomas RJ, Hards DK, Quinn JMW, Niforas P, Ng KW, Martin TJ, Gillespie MT 1999 Localization of RANKL (receptor activator of NF kappa B ligand) mRNA and protein in skeletal and extraskeletal tissues. Bone 25:525-534.
30. Silvestrini G, Ballanti P, Patacchioli F, Leopizzi M, Gualtieri N, Monnazzi P, Tremante E, Sardella D, Bonucci E 2005 Detection of osteoprotegerin (OPG) and its ligand (RANKL) mRNA and protein in femur and tibia of the rat. J Molec Histol 36:59-67.
31. Breuil V, Schmid-Antomarchi H, Schmid-Alliana A, Rezzonico R, Euller-Ziegler L, Rossi B 2003 The receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) is a new chemotactic factor for human monocytes. FASEB J 17:1751-1753.
32. Mosheimer BA, Kaneider NC, Feistritzer C, Sturn DH, Wiedermann CJ 2004 Expression and function of RANK in human monocyte chemotaxis. Arthritis Rheum 50:2309-2316.
33. Collin-Osdoby P, Rothe L, Anderson F, Nelson M, Maloney W, Osdoby P 2001 RANKL and OPG expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J Biol Chem 276:20659-20672.
34. Zhang X, Ziran N, Goater JJ, Schwarz EM, Puzas JE, Rosier RN, Zuscik M, Drissi H, O'Keefe RJ 2004 Primary murine limb bud mesenchymal cells in long-term culture complete chondrocyte differentiation: TGF-beta delays hypertrophy and PGE2 inhibits terminal differentiation. Bone 34:809-817.
35. Gartland A, Mechler J, Mason-Savas A, MacKay CA, Mailhot G, Marks SC Jr, Odgren PR 2005 In vitro chondrocyte differentiation using costochondral chondrocytes as a source of primary rat chondrocyte cultures: An improved isolation and cryopreservation method. Bone 37:530-544.
36. Drissi MH, Li X, Sheu TJ, Zuscik MJ, Schwarz EM, Puzas JE, Rosier RN, O'Keefe RJ 2003 Runx2/Cbfa1 stimulation by retinoic acid is potentiated by BMP2 signaling through interaction with Smad1 on the collagen X promoter in chondrocytes. J Cell Biochem 90:1287-1298.
37. Wang Q, Wei X, Zhu T, Zhang M, Shen R, Xing L, O'Keefe RJ, Chen D 2007 BMP-2 activates Smad6 gene transcription through bone-specific transcription factor Runx2. J Biol Chem 282:10742-10748.
38. Yanagi Y, Suzawa M, Kawabata M, Miyazono K, Yanagisawa J, Kato S 1999 Positive and negative modulation of vitamin D receptor function by transforming growth factor-beta signaling through smad proteins. J Biol Chem 274:12971-12974.
39. Komori Y, Yagi H, Nomura S, Yamaguchi A, Sasaki K, Deguchi K, Shimizu Y, Bronson RT, Gao YH, Inada M, Sato M, Okamoto R, Kitamura Y, Yoshiki S, Kishimito T 1997 Targeted disruption of Cbfa 1 results in a complete lack of bone formation owing to maturational arrest of osteoblasts. Cell 89:755-764.
40. Ducy P, Zhang R, Geoffroy V, Ridall AL, Karsenty G 1997 Osf2/Cbfa 1: A transcriptional activator of osteoblast differentiation. Cell 89:747-754.
41. Choi JY, Pratap J, Javed A, Zaidi SK, Xing L, Balint E, Dalamangas S, Boyce BF, van Wijnen AJ, Lian JB, Stein JL, Jones SN, Stein GS 2001 Subnuclear targeting of Runx/Cbfa/AML factors is essential for tissue-specific differentiation during embryonic development. Proc Natl Acad Sci USA 98:8650-8655.
42. MacDonald PN, Baudino TA, Tokumaru H, Dowd DR, Zhang C 2001 Vitamin D receptor and nuclear receptor coactivators: Crucial interactions in vitamin D-mediated transcription. Steroids 66:171-176.
43. Yanagisawa J, Yanagi Y, Masuhiro Y, Suzawa M, Watanabe M, Kashiwagi K, Toriyabe T, Kawabata M, Miyazono K, Kato S 1999 Convergence of transforming growth factor-beta and vitamin D signaling pathways on SMAD transcriptional coactivators. Science 283:1317-1321.
44. Kanatani M, Sugimoto T, Kaji H, Kobayashi T, Nishiyama K, Fukase M, Kumegawa M, Chihara K 1995 Stimulatory effect of bone morphogenetic protein-2 on osteoclast-like cell formation and bone-resorbing activity. J Bone Miner Res 10:1681-1690.
45. Horiki M, Imamura T, Okamoto M, Hayashi M, Murai J, Akira Myoui A, Ochi T, Miyazono K, Yoshikawa H, Tsumaki N 2004 Smad6/Smurf1 overexpression in cartilage delays chondrocyte hypertrophy and causes dwarfism with osteopenia. J Cell Biol 165:433-445.